Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-000460-21Phase 4Terminated
Phase 4 trial of dasatinib (2 arms), sponsored by KU Leuven. Primary endpoint: Gastrointestinal behavior of dasatinib. Started Mar 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-000460-21.